Former Global Head of Medicinal Chemistry, Small Molecule Research, Roche

Dr. Andrew Thomas is an entrepreneur focused on transforming impactful innovation in the healthcare sector. He was formerly the Global Head of Medicinal Chemistry, Small Molecule Research at Roche. More recently, he has managed two investment funds focused on Swiss technology growth companies. He received his chemistry education at the Universities of Robert Gordon, St Andrews and Cambridge and executive business development training at IMD Lausanne and London Business School. During his career, he has published more than 100 patents, peer-reviewed journals, and books, with his most notable Roche success being his team’s invention and development of Evrysdi for the treatment of spinal muscular atrophy.

Former Vice President, Discovery Chemistry and Technology, AbbVie

Dr. Stevan Djuric is President of Discovery Chemistry and Technology Consulting LLC. Previously, he served as Vice President of Discovery Chemistry and Technology at AbbVie, where he led the global Medicinal Chemistry Leadership Team and discovery chemistry organization. During his career at Abbott and AbbVie, he advanced multiple drug discovery programs into clinical development and contributed to the development of Zotarolimus and other therapeutic innovations. Dr. Djuric has authored more than 180 scientific publications and patents and serves on several scientific and editorial advisory boards.